Improved protection by recombinant BCG.

Microbes Infect

Department of Immunology, Max-Planck Institute for Infection Biology, Schumannstr. 21/22, 10117 Berlin, Germany.

Published: May 2005

Mycobacterium bovis bacille Calmette Guérin (BCG) is one of the most widely used live vaccines. Technologic advancement in genome manipulation enables the construction of recombinant BCG (rBCG) strains, which can be employed as highly immunogenic vaccines against tuberculosis with improved safety profile.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micinf.2005.03.012DOI Listing

Publication Analysis

Top Keywords

recombinant bcg
8
improved protection
4
protection recombinant
4
bcg mycobacterium
4
mycobacterium bovis
4
bovis bacille
4
bacille calmette
4
calmette guérin
4
guérin bcg
4
bcg live
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!